A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS

BACKGROUND: Inflammatory bowel disease (IBD) is a costly disease to manage due to hospitalizations, regular ambulatory monitoring, and expensive pharmaceutical therapies. While hospitalization rates have fallen, the increased use of biologics have escalated the cost of care to the healthcare system....

Descripción completa

Detalles Bibliográficos
Autores principales: Coward, S, Benchimol, E I, Bernstein, C, Avina-Zubieta, J A, Bitton, A, Hracs, L, Jones, J, Kuenzig, E, Lu, L, Murthy, S K, Nugent, Z, Otley, A R, Panaccione, R, Pena-Sanchez, J -N, Singh, H, Targownik, L E, Windsor, J W, Kaplan, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991147/
http://dx.doi.org/10.1093/jcag/gwac036.169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991147/
http://dx.doi.org/10.1093/jcag/gwac036.169

Ejemplares similares